Literature DB >> 25765235

Pyoderma gangrenosum secondary to azacitidine in myelodysplastic syndrome.

Eric Tseng1, Raed Alhusayen, Shachar Sade, Rena Buckstein, Anca Prica.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25765235     DOI： 10.1111/bjh.13341

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  Azacitidine-induced pyoderma gangrenosum at injection sites in a patient with myelodysplastic syndrome.

Authors:  C Roy; J P Adam; F Morin; É Lemieux-Blanchard; S Doucet; D Friedmann; A Belisle; D Charpentier
Journal:  Curr Oncol       Date:  2018-02-28       Impact factor: 3.677

Review 2.  [Acute lymphoblastic leukemia complicated with pyoderma gangrenosum: a case report and literatures review].

Authors:  X Shi; Z G Cui; F Hou; H Xu; H Wang; Z Su; H G Zhao
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-04-14

Review 3.  Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review.

Authors:  Roberto Maglie; Giovanni Genovese; Farzan Solimani; Alba Guglielmo; Alessandro Pileri; Francesca Portelli; Michael Hertl; Angelo Valerio Marzano; Emiliano Antiga
Journal:  Am J Clin Dermatol       Date:  2020-12       Impact factor: 7.403
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.